Ipsen Biopharmaceuticals, Inc 401(k) Review & Grade
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan
Berkeley Heights, NJWholesale Trade688 active participantsPlan year 2024
Estimate from the plan's Form 5500 filing · How we grade
$23,255Employer $ per active participant
$20,192Employee $ saved per active participant
0.05%Direct admin cost, % of plan assets
$205.8MNet plan assets, end of year
$172,518Average balance per account
Score breakdown
- Employer generosity50.0 / 50100th percentile for employer $ per participant
- Low cost21.8 / 2587th percentile for low admin cost vs. same-size plans
- Employee saving15.0 / 15100th percentile for employee $ per participant
- Plan features3 / 10Default investment
- Red-flag deductions-3 pts1 issue reported on the filing
Total score87 / 100 · Grade A
This plan vs. peers
Peers: Wholesale Trade plans with 500–2,499 active participants (603 plans).
| Measure | Percentile |
|---|---|
| Employer $ per participant | 100th |
| Lower admin cost | 87th |
| Employee saving | 100th |
| Peers that auto-enroll | 53% |
Get the monthly 401(k) report card
The best and worst plans, new grades as filings post. One email a month, no spam.
Red flags from the filing
Corrective distributions: the plan refunded $22,551 in contributions, which usually means it failed annual nondiscrimination testing.
What to do if you're in this plan
- Ipsen Biopharmaceuticals put in about $23,255 per active participant, more than the typical peer ($1,792). Contribute at least enough to collect the full match. Skipping it leaves part of your pay on the table.
- The filing shows total dollars, not the match formula. Ask HR for the Summary Plan Description so you know the exact match and vesting schedule.
- Fund expense ratios aren't in the filing. Look them up in your 404(a)(5) fee disclosure and favor low-cost index or target-date funds.
- Changing jobs? You can usually leave the money in the plan, move it to your new employer's plan, or roll it into an IRA. Don't cash out: you'd owe taxes and possibly a 10% penalty.
The raw numbers from the filing
| Employer contributions | $15,987,988 |
| Participant (employee) contributions | $13,882,284 |
| Other contributions (incl. rollovers in) | $6,311,516 |
| Administrative expenses paid from the plan | $93,898 |
| Benefits paid out | $22,416,715 |
| Net assets, start / end of year | $165.9M / $205.8M |
| Active participants, start / end of year | 692 / 683 |
| Participants with account balances | 1,193 |
| Auto-enrollment (feature code 2S) | Not reported |
| Auditor | Baker Tilly US, LLP |
Largest service providers (Schedule C)
| Fidelity Investments Institutional | $65,648 reported compensation |
| Moss Adams LLP | $28,250 reported compensation |
Source: DOL EFAST2 Form 5500 filing, acknowledgment ID 20250929145255NAL0010997649001, received 2025-09-29, EIN 26-0042539, plan #001, plan year 2024-01-01 to 2024-12-31. Verify at efast.dol.gov.